Related Experiment Video
Updated: Jun 3, 2026

Mouse In Vivo Placental Targeted CRISPR Manipulation
Published on: April 14, 2023
[Barrier role of ABC family of proteins in human placenta]
Danuta Kozłowska-Rup1, Piotr Czekaj
1Zakład Histologii, Katedra Morfologii, Slaski Uniwersytet Medyczny w Katowicach. dan.kozlowska@wp.pl
Both a pregnant woman and a fetus are exposed to a wide range of xenobiotics. Placenta provides the only link between the mother and the developing fetus. It plays a major protective role acting as a semi-permeable barrier to minimize fetal exposure to exogenous compounds. Membrane proteins taking part in the xenobiotic transport were found in human placenta, both in syncytiotrophoblast and fetal capillaries. Most importantly placental ABC transporters--P-glycoprotein, BCRP and MRP--protect placental and fetal tissues by the efflux of their substrates. However; a decline in placental ABC transporter expressions was observed in some disorders. As a result, many drugs may cross the placental barrier increasing the risk of teratogenic effects. Thus, knowledge about placental transport proteins and pharmacological control of ABC proteins activity has important clinical implications. It is very important in the context of effective and safe pharmacotherapy during pregnancy. In this review, we summarized the current state of knowledge about the barrier role of ABC transporters in the human placenta.
Both a pregnant woman and a fetus are exposed to a wide range of xenobiotics. Placenta provides the only link between the mother and the developing fetus. It plays a major protective role acting as a semi-permeable barrier to minimize fetal exposure to exogenous compounds. Membrane proteins taking part in the xenobiotic transport were found in human placenta, both in syncytiotrophoblast and fetal capillaries. Most importantly placental ABC transporters--P-glycoprotein, BCRP and MRP--protect placental and fetal tissues by the efflux of their substrates. However; a decline in placental ABC transporter expressions was observed in some disorders. As a result, many drugs may cross the placental barrier increasing the risk of teratogenic effects. Thus, knowledge about placental transport proteins and pharmacological control of ABC proteins activity has important clinical implications. It is very important in the context of effective and safe pharmacotherapy during pregnancy. In this review, we summarized the current state of knowledge about the barrier role of ABC transporters in the human placenta.
Related Concept Videos
ABC Transporters: Exporter
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Physiological Barriers
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
Factors Affecting Drug Distribution: Physiological Barriers
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:
Fetal Circulation
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
